These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 28993225)
41. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880 [TBL] [Abstract][Full Text] [Related]
42. Pediatric malignant ovarian tumors: 15 years of experience at a single institution. Yeap ST; Hsiao CC; Hsieh CS; Yu HR; Chen YC; Chuang JH; Sheen JM Pediatr Neonatol; 2011 Jun; 52(3):140-4. PubMed ID: 21703555 [TBL] [Abstract][Full Text] [Related]
43. Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period. Chu SM; Ming YC; Chao HC; Lai JY; Chen JC; Yung CP; Luo CC Chang Gung Med J; 2010; 33(2):152-6. PubMed ID: 20438667 [TBL] [Abstract][Full Text] [Related]
44. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
45. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors]. Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428 [TBL] [Abstract][Full Text] [Related]
46. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change? Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495 [TBL] [Abstract][Full Text] [Related]
47. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Veras E; Deavers MT; Silva EG; Malpica A Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463 [TBL] [Abstract][Full Text] [Related]
48. [Study on management of low potential malignancy ovarian tumors]. Takahashi A; Ukita M; Nunotani T; Kanto T; Natsuyama S Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1797-802. PubMed ID: 2592805 [TBL] [Abstract][Full Text] [Related]
49. A retrospective analysis of borderline ovarian tumors in a Greek university hospital. Liapis A; Bakalianou K; Iavazzo C; Salakos N; Paltoglou G; Kondi-Pafiti A Eur J Gynaecol Oncol; 2008; 29(4):383-5. PubMed ID: 18714575 [TBL] [Abstract][Full Text] [Related]
50. Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D. Sornsukolrat S; Tuipae S J Med Assoc Thai; 2012 Sep; 95(9):1141-8. PubMed ID: 23140030 [TBL] [Abstract][Full Text] [Related]
51. Prognostic factors in children with extracranial malignant germ cell tumors: a monocentric pediatric Tunisian study. Fedhila F; Rhayem S; Hafsi H; Douira W; Doghri R; Khemiri M; Mrad K; Bellagha I; Zouari B; Barsaoui S Tunis Med; 2016 Apr; 94(4):309-314. PubMed ID: 27704516 [TBL] [Abstract][Full Text] [Related]
52. Outcome of ovarian cancer patients who underwent incomplete surgical staging. Panprom P; Lertkhachonsuk R J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859 [TBL] [Abstract][Full Text] [Related]
53. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
54. Outcome and prognostic factors in ovarian germ cell malignancies. Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426 [TBL] [Abstract][Full Text] [Related]
55. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162 [TBL] [Abstract][Full Text] [Related]
56. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors]. Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456 [TBL] [Abstract][Full Text] [Related]
57. Ovarian cystectomy in the treatment of apparent early-stage immature teratoma. Zhao T; Liu Y; Wang X; Zhang H; Lu Y J Int Med Res; 2017 Apr; 45(2):771-780. PubMed ID: 28415950 [TBL] [Abstract][Full Text] [Related]
59. Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study. Helpman L; Yaniv A; Beiner ME; Aviel-Ronen S; Perri T; Ben-Baruch G; Hogen Ben-David L; Jakobson-Setton A; Korach J Acta Obstet Gynecol Scand; 2017 Nov; 96(11):1300-1306. PubMed ID: 28815550 [TBL] [Abstract][Full Text] [Related]
60. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients. Zang RY; Yang WT; Shi DR; Xing Y; Cai SM J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]